EVALUATION OF ERYTHROPOIETIN PRODUCTION IN DOGS WITH REDUCED FUNCTIONAL RENAL TISSUE

被引:4
|
作者
OISHI, A
SAKAMOTO, H
SHIMIZU, R
OHASHI, F
TAKEUCHI, A
机构
[1] UNIV OSAKA PREFECTURE, FAC AGR, DEPT VET SURG, SAKAI, OSAKA 591, JAPAN
[2] UNIV TOKYO, FAC AGR, DEPT VET SURG, BUNKYO KU, TOKYO 113, JAPAN
关键词
BIOASSAY; CANINE; ERYTHROPOIETIN; FUNCTIONAL RENAL TISSUE; PHLEBOTOMY;
D O I
10.1292/jvms.55.543
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
This study was designed to determine the quantity of functional renal tissue needed to maintain homeostasis of red blood cell production by evaluating the erythropoietin (EPO) production response to phlebotomic stimulation in the 1/2- and 1/4-kidney dogs surgically prepared. The results showed that the reduction in functional renal tissue caused a decrease in EPO production, which led to the delay in recovery from anemia. In the anemic progress stage, the plasma EPO level showed a transition proportional to the quantity of functional renal tissue immediately after the operation for tissue reduction. The 1/2-kidney dog group still kept such proportional relation even in the recovery stage. Thus, the half of the normal renal tissue was considered sufficiently contributory to EPO production needed to maintain homeostasis of red blood cell production. However, the 1/4-kidney dog group precipitously decreased in plasma EPO level in the recovery stage and fell into an extremely unfavorable anemia. This indicated that homeostatic maintenance in erythropoiesis would be impossible more below a quater of normal renal tissue. These findings disclosed that reduction in functional renal tissue quantity would sensitively influence homeostatic maintenance of red blood cell production through the decrease in EPO production, even if it does not affect renal function concerned with urine production.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 50 条
  • [1] EVALUATION OF PHLEBOTOMY-INDUCED ERYTHROPOIETIN PRODUCTION IN THE DOG
    OISHI, A
    SAKAMOTO, H
    SHIMIZU, R
    OHASHI, F
    TAKEUCHI, A
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1993, 55 (01) : 51 - 58
  • [2] THE ROLE OF HYPOXIA IN RENAL PRODUCTION OF ERYTHROPOIETIN
    FISHER, JW
    NAKASHIMA, J
    CANCER, 1992, 70 (04) : 928 - 939
  • [3] Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives
    Villa, Pia
    van Beek, Johan
    Larsen, Anna Kirstine
    Gerwien, Jens
    Christensen, Soren
    Cerami, Anthony
    Brines, Michael
    Leist, Marcel
    Ghezzi, Pietro
    Torup, Lars
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (03) : 552 - 563
  • [4] Long-term erythropoietin in rats with reduced renal mass
    Torralbo, A
    Blanco, J
    Fontanellas, A
    Herrero, JA
    Cruceyra, A
    GonzalezLopez, P
    Barrientos, A
    NEPHRON, 1996, 73 (02) : 280 - 285
  • [5] ERYTHROPOIETIN PRODUCTION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    KATO, A
    HISHIDA, A
    KUMAGAI, H
    FURUYA, R
    NAKAJIMA, T
    HONDA, N
    RENAL FAILURE, 1994, 16 (05) : 645 - 651
  • [6] EVALUATION OF PLASMA ERYTHROPOIETIN LEVELS IN NORMAL ADULT DOGS BY INVIVO BIOASSAY USING CONCENTRATED PLASMA
    OISHI, A
    SAKAMOTO, H
    SHIMIZU, R
    OHASHI, F
    TAKEUCHI, A
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1992, 54 (04) : 621 - 628
  • [7] Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure
    Cowgill, LD
    James, KM
    Levy, JK
    Browne, JK
    Miller, A
    Lobingier, RT
    Egrie, JC
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1998, 212 (04): : 521 - +
  • [8] Erythropoiesis and erythropoietin production in renal and sickle cell anemias.
    Erslev, AJ
    Besarab, A
    Ballas, SK
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1997, 42 (01): : 13 - 15
  • [9] PREVALENCE OF PARANEOPLASTIC ERYTHROPOIETIN PRODUCTION BY RENAL-CELL CARCINOMAS
    GROSS, AJ
    WOLFF, M
    FANDREY, J
    MIERSCH, WD
    DIECKMANN, KP
    JELKMANN, W
    CLINICAL INVESTIGATOR, 1994, 72 (05): : 337 - 340
  • [10] Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function
    Slagman, Maartje C. J.
    Sinkeler, Steef J.
    Hemmelder, Marc H.
    Waanders, Femke
    Vogt, Liffert
    Kluin-Nelemans, Hanneke C.
    Navis, Gerjan
    Laverman, Gozewijn D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (10) : 3256 - 3260